Is it time to abandon functional imaging in the study of neuroprotection?

Movement Disorders

Volumn 17, Issue 2, 2002, Pages 229-232

  Morrish, Paul ^a  

^a PRINCESS ROYAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE; DOPAMINE RECEPTOR STIMULATING AGENT; FLUORODEOXYGLUCOSE F 18; LEVODOPA; PERGOLIDE; PRAMIPEXOLE; ROPINIROLE;

BRAIN FUNCTION; CLINICAL TRIAL; CYTOTOXICITY; DOPAMINERGIC NERVE CELL; DRUG EFFECT; EDITORIAL; HUMAN; IMAGING SYSTEM; NEUROPROTECTION; NEUROTOXICITY; OUTCOMES RESEARCH; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ANTIPARKINSON AGENTS; BRAIN; CLINICAL TRIALS; DISEASE PROGRESSION; HUMANS; INDOLES; LEVODOPA; PARKINSON DISEASE; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TREATMENT OUTCOME;

EID: 0036523881     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.10112     Document Type: Editorial

References (10)

1. 18F]dopa PET. J Neurol Neurosurg Psychiatry 1998;64:314-319.
2. Seibyl JP, Marek KL, Quinlan D, Sheff K, Zoghbi S, Zea-Ponce Y, Baldwin RM, Fussell B, Smith EO, Charney DS, et al. Decreased single-photon emission tomographic [123I]B-CIT striatal uptake correlates with symptom severity in Parkinson's disease. Ann Neurol 1995;38:589-598.
3. Oertel WH, Schwarz J, Leenders KL, Hundemer HP, Lledo A, Wolters EC. Results of a three year randomized, double-blind PET-controlled study of pergolide vs. L-dopa as monotherapy in early Parkinson's disease (PELMOPET-trial). J Neurol Sci 2001; 187:(S1)444.
4. Parkinson Study Group. Pramipexole vs levodopa as initial treatment for Parkinson's disease. A randomized controlled trial. JAMA 2000;284:1931-1938.
5. 18F]fluorodopa studies correlate with dopamine cell counts and levels. Ann Neurol 1993;34:324-330.
6. Ward CD. Does selegiline delay progression of Parkinson's disease? A critical re-evaluation of the DATATOP study. J Neurol Neurosurg Psychiatry 1994;57:217-220.
7. 18F]dopa-PET study. Brain 1999;122:163-180.
8. Vickrey BG. Getting oriented to patient-oriented outcomes. Neurology 1999;53:662-663.
9. 18F]dopa PET scanning. J Neurol Sci 2001;187: S239.
10. 18F]dopa PET study of the progression of Parkinson's disease and it's treatment by embryonic implantation. DM Thesis. 1997. Oxford University, Oxford, U.K.